13F

Stock

Lexaria Bioscience Corp.

LEXX · held by 24 managers

Reported value

$1.05M

Holders

24

+1 new · −0 exited

Holders’ est. mark

−$57

Price effect on 1 books still in the name

Largest holder

$290.6K

Invenomic Capital Management LP

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Invenomic Capital Management LP470.9K$290.6KHeld
UBS Group AG361.3K$222.9KHeld
Vanguard258.8K$159.7KHeld
GEODE CAPITAL MANAGEMENT, LLC219.7K$135.6KHeld
TORONTO DOMINION BANK140K$86.5KHeld
Byrne Asset Management LLC105.5K$65.1KHeld
State Street39.3K$24.2KHeld
BlackRock, Inc.27.4K$16.9KHeld
Krilogy Financial LLC19.7K$16KHeld
NORTHERN TRUST CORP18.4K$11.3KHeld
Renaissance Technologies15.6K$9.63KHeld
BANK OF MONTREAL /CAN/14.1K$8.69KHeld
ROYAL BANK OF CANADA7.28K$4KHeld
OSAIC HOLDINGS, INC.2.19K$1.36KHeld
Federation des caisses Desjardins du Quebec382$233Held
BANK OF AMERICA CORP /DE/203$126−$57Cut−$38
MAI Capital Management200$124Held
Farther Finance Advisors, LLC166$102Held
TWO SIGMA SECURITIES, LLC22.9K$96Held
Tower Research Capital LLC (TRC)32$20Held
GABLES CAPITAL MANAGEMENT INC.13$8Held
MORGAN STANLEY3$2New
Clear Street Group Inc.200$1Held
HRT FINANCIAL LP105.5K$0Held

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.